Keros Therapeutics (KROS) Times Interest Earned (2019 - 2022)
Historic Times Interest Earned for Keros Therapeutics (KROS) over the last 4 years, with Q1 2022 value amounting to -$24126.0.
- Keros Therapeutics' Times Interest Earned fell 5299.64% to -$24126.0 in Q1 2022 from the same period last year, while for Dec 2022 it was -$114790.0, marking a year-over-year decrease of 71450.34%. This contributed to the annual value of -$114790.0 for FY2022, which is 71450.34% down from last year.
- According to the latest figures from Q1 2022, Keros Therapeutics' Times Interest Earned is -$24126.0, which was down 5299.64% from -$4866.0 recorded in Q4 2021.
- Over the past 5 years, Keros Therapeutics' Times Interest Earned peaked at -$775.33 during Q3 2019, and registered a low of -$24126.0 during Q1 2022.
- Its 4-year average for Times Interest Earned is -$9955.0, with a median of -$8444.0 in 2020.
- As far as peak fluctuations go, Keros Therapeutics' Times Interest Earned crashed by 72338.74% in 2020, and later soared by 6338.88% in 2021.
- Keros Therapeutics' Times Interest Earned (Quarter) stood at -$775.33 in 2019, then tumbled by 1614.23% to -$13291.0 in 2020, then soared by 63.39% to -$4866.0 in 2021, then plummeted by 395.81% to -$24126.0 in 2022.
- Its Times Interest Earned stands at -$24126.0 for Q1 2022, versus -$4866.0 for Q4 2021 and -$20197.0 for Q3 2021.